Search - tctmd.com

Displaying 201 - 220 of 491

Sort: Relevancy | Date

Presentation TCT 2018

Algorithmic Pharmacology Recommendations for the PCI Patient With Atrial Fibrillation

Presenter: Philip M. Urban, Robert W. Yeh, C. Michael Gibson

September 22, 2018

Presentation TCT 2018

Case Introduction: A Patient With Non-Valvular Atrial Fibrillation

Presenter: Martina Kelly Speight, Asma Hussaini, David P. Lee, Elizabeth M. Perpetua

September 21, 2018

Presentation TCT 2018

TAVR in the Patient With Atrial Fibrillation and Contraindications to Chronic Anticoagulation

Presenter: Anibal A. Damonte

September 21, 2018

Presentation TCT 2018

Atrial Fibrillation and ACS/PCI: The End of Triple Therapy?

Presenter: Jeroen J. Bax, Stephan Windecker

September 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Rare Case of Platypnea-Orthodeoxia Syndrome Developing After Atrial Fibrillation Ablation Necessitating Percutaneous Closure of the Septal Puncture Site

Presenter: Horst Sievert, Robert J. Sommer, Nadim Geloo, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Indications and Uncertainties for Atrial Fibrillation Treatment: Risk Scores, Single AF Episode, Post-CABG AF, Valvular vs. Nonvalvular, and More

Presenter: William A. Gray, Gregg W. Stone, Vivek Y. Reddy

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Atrial Fibrillation + PCI: The Myths and Realities of Triple Therapy

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Ashish Pershad

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Gregg W. Stone

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

An Introduction to the WATCH-TAVR Trial Combining TAVR and LAAC

Presenter: Amar Krishnaswamy

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

European Perspectives and Updates From a Randomized Trial Combining TAVR and LAAC

Presenter: Fabian Nietlispach

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Presenter: George D. Dangas

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Growing Conundrum: Coronary Access After TAVR Technical Tips and Tricks

Presenter: James B. Hermiller Jr

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to Consider CABG, Timing of PCI and TAVR, and Completeness of Revascularization)

Presenter: Torsten P. Vahl

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

The Role of MitraClip After TAVR: A Case-Based Tutorial (Who, When, and How)

Presenter: Hüseyin Ince

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Clinical Decision-Mmaking in AS and MR Patients: Choosing the Best Patients for Multivalve Interventions

Presenter: Anita Asgar

June 21, 2018

Presentation

Discrepancy Between Physician Perception, Objective Risks in A-fib Patients Undergoing PCI

April 27, 2018

Presentation ECHO 2018

Echo Evaluation of The Adult with Unoperated Congenital Heart Disease

Presenter: Karen Stout

April 20, 2018

Comparison of Effectiveness, Safety, and The Net Clinical Outcome Between Different Direct Oral Anticouagulants

Presentation ACC 2018

Comparison of Effectiveness, Safety, and The Net Clinical Outcome Between Different Direct Oral Anticoagulants

Presenter: Steve Deitelzweig

March 12, 2018

Presentation JIM 2018

Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing PCI: "Dual Therapy is the right choice”

Presenter: Roxana Mehran

February 23, 2018

Presentation TTT 2018

Use of NOAC in Coronary Artery Disease

Presenter: Tsung-Hsien Lin

January 14, 2018

Advertisement

Algorithmic Pharmacology Recommendations for the PCI Patient With Atrial Fibrillation

Case Introduction: A Patient With Non-Valvular Atrial Fibrillation

TAVR in the Patient With Atrial Fibrillation and Contraindications to Chronic Anticoagulation

Atrial Fibrillation and ACS/PCI: The End of Triple Therapy?

A Rare Case of Platypnea-Orthodeoxia Syndrome Developing After Atrial Fibrillation Ablation Necessitating Percutaneous Closure of the Septal Puncture Site

Indications and Uncertainties for Atrial Fibrillation Treatment: Risk Scores, Single AF Episode, Post-CABG AF, Valvular vs. Nonvalvular, and More

Atrial Fibrillation + PCI: The Myths and Realities of Triple Therapy

Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices

An Introduction to the WATCH-TAVR Trial Combining TAVR and LAAC

European Perspectives and Updates From a Randomized Trial Combining TAVR and LAAC

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

A Growing Conundrum: Coronary Access After TAVR Technical Tips and Tricks

Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to Consider CABG, Timing of PCI and TAVR, and Completeness of Revascularization)

The Role of MitraClip After TAVR: A Case-Based Tutorial (Who, When, and How)

Clinical Decision-Mmaking in AS and MR Patients: Choosing the Best Patients for Multivalve Interventions

Discrepancy Between Physician Perception, Objective Risks in A-fib Patients Undergoing PCI

Echo Evaluation of The Adult with Unoperated Congenital Heart Disease

Comparison of Effectiveness, Safety, and The Net Clinical Outcome Between Different Direct Oral Anticoagulants

Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing PCI: "Dual Therapy is the right choice”

Use of NOAC in Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content